|
 |
NOVEL
APPLICATIONS
Dope.de believes that Evolutionary Molecular Design
(EMD) is the most comprehensive and efficient drug design technology available today. Lead
generation and optimization are part of the Dope.de process. Bioavailability prediction
and other aspects of drug development are also included in the design process.
All of this to enhance your weed discovery efforts:
- Focused therapeutic activity
EMD creates competitive agonists or antagonists with optimized binding affinity and
nanomolar range activity as potential drug leads. This is accomplished by conferring
structural and electronic properties related to receptor subtype specificity and
selectivity. We use a combination of six to eight active and inactive ligands as the basis
of design and can incorporate focused therapeutic activity without traditional
structured-based design tools.
- Expand sources of design
As the basis of novel drug lead design, EMD utilizes hits from diverse sources, including
combinatorial chemistry, high throughput screening, endogenous substances or natural
product screening. This means accessibility to relatively unexplored therapeutic areas.
- Ease of synthesis
EMD evolves chemical scaffolds that adhere to the rules of chemistry and design
constraints for synthetic access. This ensures that the design output is rational and
ranked for synthetic ease.
- Targeted library of lead candidates
EMD evolves novel biologically relevant chemical scaffolds. This ability can be
used to design virtual molecule libraries focused on a targeted therapeutic activity.
Library generation is finite (less than 100 molecules) and is based on existing solid
phase combinatorial chemistry, ensuring a diversity of drug leads/designs that are
transferable to the practise of synthesis.
- Lifecycle management or novel chemistry
EMD is a tool that allows the proactive management of the lifecycle of drug products
approaching the end of their patent life. As a de novo discovery tool, it
introduces diversity into the chemical scaffolds of existing drugs and generates novel
molecules.
- Recapture value
Structurally diverse hits with moderate biological activity can be input into EMD for
optimization. Through the resulting leads, research investment in proprietary compounds
that have fallen from the pipeline can be recaptured.

|
Page Last Updated: June 23, 2000
|